受强制性开放获取政策约束的文章 - Russ B Altman了解详情
整体NIHCZINSFHHMIVASNSFAHACIHRDFGMRCEuropean CommissionGovernment of SpainDOEDoDGBMFSwedish Research CouncilA*StarBHFNIHRWellcomeHewlettMacArthurNSERCNSFCDNRFINSERMKnut and Alice Wallenberg FoundationCancer Research UKBMBFResearch Grants Council, Hong KongTUBITAKV Foundation, USALeducq Foundation, USA
无法在其他位置公开访问的文章:7 篇
Neurotoxicity of generic anesthesia agents in infants and children: an orphan research question in search of a sponsor
BM Psaty, R Platt, RB Altman
Jama 313 (15), 1515-1516, 2015
强制性开放获取政策: US National Institutes of Health
Data re-identification: societal safeguards
RB Altman, EW Clayton, IS Kohane, BA Malin, DM Roden
Science 339 (6123), 1032-1033, 2013
强制性开放获取政策: US National Institutes of Health
Personalization in practice
R Iyengar, RB Altman, O Troyanskya, GA FitzGerald
Science 350 (6258), 282-283, 2015
强制性开放获取政策: US National Institutes of Health
Predicting cancer drug response: advancing the DREAM
RB Altman
Cancer Discovery 5 (3), 237-238, 2015
强制性开放获取政策: US National Institutes of Health
Genomics in the clinic: ethical and policy challenges in clinical next-generation sequencing programs at early adopter USA institutions
LC Milner, NA Garrison, MK Cho, RB Altman, L Hudgins, SJ Galli, ...
Personalized medicine 12 (3), 269-282, 2015
强制性开放获取政策: US National Institutes of Health
Toward a framework for risk mitigation of potential misuse of artificial intelligence in biomedical research
AA Trotsyuk, Q Waeiss, RT Bhatia, BJ Aponte, IML Heffernan, ...
Nature Machine Intelligence, 1-8, 2024
强制性开放获取政策: Chan Zuckerberg Initiative
Table. US Patient Cohorts Used for Training Clinical Machine Learning Algorithms, by Statea
A Kaushal, R Altman, C Langlotz
Radiol 17 (6), 796-803, 2020
强制性开放获取政策: US National Institutes of Health
可在其他位置公开访问的文章:344 篇
Pharmacogenomics knowledge for personalized medicine
M Whirl‐Carrillo, EM McDonagh, JM Hebert, L Gong, K Sangkuhl, ...
Clinical Pharmacology & Therapeutics 92 (4), 414-417, 2012
强制性开放获取政策: US National Institutes of Health
Doxorubicin pathways: pharmacodynamics and adverse effects
CF Thorn, C Oshiro, S Marsh, T Hernandez-Boussard, H McLeod, ...
Pharmacogenetics and genomics 21 (7), 440-446, 2011
强制性开放获取政策: US National Institutes of Health
Estimation of the warfarin dose with clinical and pharmacogenetic data
International Warfarin Pharmacogenetics Consortium
New England Journal of Medicine 360 (8), 753-764, 2009
强制性开放获取政策: US National Institutes of Health
Guidelines for investigating causality of sequence variants in human disease
DG MacArthur, TA Manolio, DP Dimmock, HL Rehm, J Shendure, ...
Nature 508 (7497), 469-476, 2014
强制性开放获取政策: US National Institutes of Health
Personal omics profiling reveals dynamic molecular and medical phenotypes
R Chen, GI Mias, J Li-Pook-Than, L Jiang, HYK Lam, R Chen, E Miriami, ...
Cell 148 (6), 1293-1307, 2012
强制性开放获取政策: US National Institutes of Health, Government of Spain
The chemical genomic portrait of yeast: uncovering a phenotype for all genes
ME Hillenmeyer, E Fung, J Wildenhain, SE Pierce, S Hoon, W Lee, ...
Science 320 (5874), 362-365, 2008
强制性开放获取政策: US National Institutes of Health, Canadian Institutes of Health Research
Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image features
KH Yu, C Zhang, GJ Berry, RB Altman, C Ré, DL Rubin, M Snyder
Nature communications 7 (1), 12474, 2016
强制性开放获取政策: US National Institutes of Health, Howard Hughes Medical Institute
Machine learning in chemoinformatics and drug discovery
YC Lo, SE Rensi, W Torng, RB Altman
Drug discovery today 23 (8), 1538-1546, 2018
强制性开放获取政策: US National Institutes of Health
Data-driven prediction of drug effects and interactions
NP Tatonetti, PP Ye, R Daneshjou, RB Altman
Science translational medicine 4 (125), 125ra31-125ra31, 2012
强制性开放获取政策: US National Institutes of Health, Howard Hughes Medical Institute
Clinical assessment incorporating a personal genome
EA Ashley, AJ Butte, MT Wheeler, R Chen, TE Klein, FE Dewey, ...
The Lancet 375 (9725), 1525-1535, 2010
强制性开放获取政策: US National Institutes of Health, Howard Hughes Medical Institute, John D …
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing
JA Johnson, L Gong, M Whirl‐Carrillo, BF Gage, SA Scott, CM Stein, ...
Clinical Pharmacology & Therapeutics 90 (4), 625-629, 2011
强制性开放获取政策: US National Institutes of Health, Swedish Research Council
Human induced pluripotent stem cell–derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity
PW Burridge, YF Li, E Matsa, H Wu, SG Ong, A Sharma, A Holmström, ...
Nature medicine 22 (5), 547-556, 2016
强制性开放获取政策: US National Institutes of Health, American Heart Association
Metformin pathways: pharmacokinetics and pharmacodynamics
L Gong, S Goswami, KM Giacomini, RB Altman, TE Klein
Pharmacogenetics and genomics 22 (11), 820-827, 2012
强制性开放获取政策: US National Institutes of Health
出版信息和资助信息由计算机程序自动确定